589 related articles for article (PubMed ID: 23312605)
21. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
Huang TS; Lee SS; Hsueh PR; Tsai HC; Chen YS; Wann SR; Leu HS; Ko WC; Yan JJ; Yuan SZ; Chang FY; Lu JJ; Wang JH; Wang HK; Liu YC
J Formos Med Assoc; 2008 Apr; 107(4):281-7. PubMed ID: 18445541
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic resistance in
Jayasingam SD; Zin T; Ngeow YF
Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
[TBL] [Abstract][Full Text] [Related]
23. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
24. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
[TBL] [Abstract][Full Text] [Related]
26. Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates.
Lee MR; Ko JC; Liang SK; Lee SW; Yen DH; Hsueh PR
Int J Antimicrob Agents; 2014 May; 43(5):438-41. PubMed ID: 24718088
[TBL] [Abstract][Full Text] [Related]
27. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
Kamada K; Yoshida A; Iguchi S; Arai Y; Uzawa Y; Konno S; Shimojima M; Kikuchi K
Sci Rep; 2021 Jun; 11(1):12208. PubMed ID: 34108590
[TBL] [Abstract][Full Text] [Related]
28. Rapidly growing mycobacteria in Singapore, 2006-2011.
Tang SS; Lye DC; Jureen R; Sng LH; Hsu LY
Clin Microbiol Infect; 2015 Mar; 21(3):236-41. PubMed ID: 25658536
[TBL] [Abstract][Full Text] [Related]
29. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M
Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569
[TBL] [Abstract][Full Text] [Related]
30.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
He G; Wu L; Zheng Q; Jiang X
Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
[No Abstract] [Full Text] [Related]
33. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
34. [Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test].
García-Agudo L; García-Martos P; Jesús I; Rodríguez-Iglesias M
Rev Med Chil; 2009 Jul; 137(7):912-7. PubMed ID: 19802419
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Zhang Z; Lu J; Song Y; Pang Y
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
[TBL] [Abstract][Full Text] [Related]
37.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
[TBL] [Abstract][Full Text] [Related]
38. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
40.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
